Candid-B cream in the treatment of candidiasis with inflammatory dermatoses--National Study Group.
Physicians (n = 84) across the country prescribed candid-B cream (clotrimazole 1% + beclomethasone dipropionate 0.025%) on 822 patients suffering from candidiasis with inflammatory diseases to evaluate the efficacy and safety of the combination. The results showed reduction in severity was more than 80% for all symptoms/signs except scaling and lichenification where the reduction was 76.05% and 66.03% respectively. Only one patient complained of adverse reaction. So in the treatment of coexisting candidiasis and inflammatory dermatoses the combination of clotrimazole 1% + beclomethasone 0.025% (candid-B cream) was found to be highly effective.
Wadhwa
S L
SL
Department of Dermatology and Venereology, TN Medical College and BYL Nair Hospital, Mumbai.
Thomas
J
J
Ainapure
S S
SS
Desai
A
A
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001507:Beclomethasone / Q000008:administration & dosage* / Q000009:adverse effects; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy*; D003022:Clotrimazole / Q000008:administration & dosage* / Q000009:adverse effects; D003872:Dermatitis / Q000188:drug therapy* / Q000382:microbiology; D004338:Drug Combinations; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007194:India; D008297:Male; D008875:Middle Aged
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D004338:Drug Combinations; D005938:Glucocorticoids; D003022:Clotrimazole; D001507:Beclomethasone